← Back to front page
United States · Platforms & data · Yahoo Finance

Mammogen Launches Leadership Council to Unite Industry Experts and Survivors, Names Former Quest Diagnostics CMO Dr. Yuri Fesko as Founding Member

Published by Yahoo Finance · United States 8 h ago
Mammogen, Inc.
Mammogen, Inc. · Yahoo Finance

Detailed summary

New council will help shape clinical adoption, strategic partnerships and patient access as Mammogen advances its genTRU-breast™ diagnostic through prospective clinical validation…

New council will help shape clinical adoption, strategic partnerships and patient access as Mammogen advances its genTRU-breast™ diagnostic through prospective clinical validation

NEWPORT BEACH, Calif., Nov. 17, 2026 (GLOBE NEWSWIRE) -- Mammogen, a molecular diagnostics company validating blood-based RNA technology for breast cancer detection, today announced the formation of its Leadership Council and the appointment of Yuri Fesko, M.D., former Chief Medical Officer of Quest Diagnostics and current Chief Medical Officer of Quanterix, as its founding member.

Established as Mammogen advances its genTRU-breast™ diagnostic technology through prospective clinical validation, the Leadership Council is designed to accelerate scientific innovation into real-world patient impact. Moving beyond the traditional scientific advisory board model, the Council will unite leaders across clinical medicine, diagnostics, healthcare delivery and commercial strategy with breast cancer survivors to help shape the company's approach to clinical adoption, strategic partnerships and patient access.

"We are bringing together the people who understand what it actually takes to change how breast cancer is detected," said Elizabeth Cormier-May, CEO of Mammogen. "Breakthrough science alone does not change healthcare. It takes clinical conviction, commercial execution, healthcare system adoption and the voices of the women whose lives depend on getting it right. Our Leadership Council is designed to connect those forces from the outset. This is how we intend to move from innovation to meaningful impact."

Founding member Dr. Fesko brings extensive experience spanning clinical oncology, precision medicine, laboratory diagnostics and healthcare leadership. He currently serves as Chief Medical Officer of Quanterix, a company advancing ultra-sensitive biomarker detection technologies, and previously served as Chief Medical Officer of Quest Diagnostics, one of the nation's largest diagnostic testing…

During…

Opening of the article, excerpted from Yahoo Finance. To read the rest, open the article on the publisher's site.

Read the full article on Yahoo Finance Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (finance.yahoo.com)

Also worth reading